Navigation Links
Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
Date:2/6/2008

Union asks board member to seek restatement of Beth Israel Deaconess Medical Center audit

BOSTON, Feb. 6 /PRNewswire-USNewswire/ -- Boston Properties executive and director Douglas T. Linde should apply the same Sarbanes-Oxley standards used by Boston Properties and other publicly traded companies to his role on the board of Beth Israel Deaconess Medical Center (BIDMC), according to labor group 1199 SEIU United Healthcare Workers East. Linde is also the president and CFO of Boston Properties.

1199 SEIU asserts that board members who serve on publicly traded companies covered by Sarbanes-Oxley should apply their knowledge of Sarbanes-Oxley disclosure standards in their non-profit roles.

Sarbanes-Oxley does not apply directly to non-profit organizations. However, under Massachusetts law, non-profit directors must use their specialized knowledge and experience in their role as non-profit fiduciaries (Mass. Gen. Laws ch. 180 section 6C).

BIDMC's audit disclosures appear to commingle bad debt and charity care, a practice under scrutiny by the IRS and Congress. Charity care is a key metric for non-profits.

If Sarbanes-Oxley were applied to non-profit organizations, BIDMC's reporting would likely not meet the "real time" and "plain English" requirements of Sarbanes-Oxley (SOX section 409) in disclosing charity care and bad debt. Inadequate charity care disclosure may endanger a hospital's state or local tax exemptions or expose the institution to other regulatory consequences.

A letter sent to Linde and other Sarbanes-Oxley affected members of the boards of BIDMC and its parent organization CareGroup reads, "Your breadth of experience in the private sector combined with your service on non-profit BIDMC's board of directors uniquely positions you to recognize the deficiencies in BIDMC's financial reporting." The letter asks that fiduciaries request the withdrawal and revision of BIDMC's 2005 and 2006 audits in ord
'/>"/>

SOURCE 1199 SEIU United Healthcare Workers East
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...n Washington D.C. , NewYorkCity , LosAngel...GrowthandRevitalization ,, WASHINGTON,Nov.23 ...ngproviderofdialysisservices,todaywaslaudedbyD.C.o...lioninvestmentinIndustrialBankaspartofaninitiative...a,sinvestmentinWashington,D.C.ispartofthedialysisc...
(Date:11/23/2009)..., WHAT: ,, TheBerylInstitute, theresearchan...adinghealthcareexclusivecallcenter,issponsoringafr...nerationwithapositivecustomerserviceexperience.Hos...arwillsupplementHowe,sJune2009whitepaper,"Customer...showconsumerswillultimatelytransformhealthcaredeli...
(Date:11/23/2009)...istheeconomyaffectingpeople,swellness?Accordingtoa...amp;theEconomy,theeconomyismakinguscollectivelymor...rciseanddiettoonethatismoreinwardlyfocusedonadapti...amaticfindingwasthechangeinconsumers,definitionofw...ndwellbeingtotoday,smorerelevantconcernsaboutadapt...
(Date:11/23/2009)...eases Society of America (IDSA) has asked for a co...opean Union to further the Society,s mission to ac... the next 10 years, known as the 10 x ,20 Initiati...ified antimicrobial resistance as one of the three...ean Union report confirms there are just 15 antiba...
(Date:11/23/2009)...--ThousandsofpeoplewithiPhoneshavealreadydownloade...etesbettermanagetheirdiseasethroughabetterundersta...rmanagetheirbloodsugar.Nowit,sbecomeeveneasierthro..., RocheDiabetesCare,themakeroftheACCU-CHEK®li...spartneredwithMYLEstoneHealth,thedeveloperofGlucos...
Breaking Medicine News(10 mins):Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3
...s Chance to Make a Difference, ROSEMONT, Ill., Ju...lectors Convention confirmed today that the $25,00...nds and, based on,overwhelmingly favorable online ... Ill., The Bartman signing is scheduled for 1 p.m...
...ain populations if people with HIV follow potentia...m the Swiss Federal Commission for HIV/AIDS, Unive... The research from UNSW,s National Centre in HIV ... stated that people with HIV receiving effective a...
...(Nasdaq: CRDC ) today announced that it will rele...r and year ended June 30, 2008 on Tuesday, August,... management will host a,conference call at 4:30 p....rence call on August 5, 2008 at 4:30 p.m.,Eastern ...
...quipment, Inc. (OTC: SHOM) announced today that th...or solid growth. Industry statistics,suggest a ver... to the,latest projections from the U.S. Bureau of... Tucker, President and CEO,of the Company stated, ...
...,Inc. (Nasdaq: GHDX ) today announced that the co...uesday, August 5, 2008 at 4:30 p.m. Eastern Time t...s. The call and webcast,will follow the release of...ern,Time via phone, please dial (877) 356-8064 fro...
... and,humidity rise, mold invades thousands of home... mold, and invisible mold spores cause countless,a...tions, according to the,American College of Allerg...ecompose floors,walls, and other structures., For...
Other Medicine News:Health News:Fans Encourage Steve Bartman to Accept $25,000 Autograph Offer 2Health News:A dangerous precedent in HIV 2Health News:Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday, August 5, 2008 2Health News:Southern Home Medical's Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry 2Health News:Genomic Health to Announce Second Quarter 2008 Financial Results and Host Conference Call on Tuesday, August 5, 2008 2Health News:Creating a Healthy Home Environment: Mold and Mildew Free 2
(Date:11/23/2009)...re-FirstCall/--WoundManagementTechnologies,Inc.,(O...ialtymedicalproducts,announcedthatithasfileditQ320...gementbusinessupdatetoillustratethedevelopmentsdur...d33.5%to$102,926vs.Q32008salesof$77,084. , Sh...s.Q32008shareholderequityof$(321,257) , Total...
(Date:11/23/2009)...tCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:CBA...y( http://www.cordblood-america.com )focusedonbrin...nsurancepolicy,tofamiliesnationwideandinternationa...thCEOandco-founderMatthewSchisslerisnowavailable. ...2875811 . ,, Intheinterview,Mr.Schisslerupdates...
(Date:11/23/2009)...-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"ort...tationofclinicaltrialdataonNGX426,theCompany,soral...gonist,atthe12thInternationalConferenceontheMechan...-21inSanFrancisco.TheresultsofthestudyledbyMarkWal...nterforPainMedicineoftheUniversityofCaliforniaatSa...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 1Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 2Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 3CoAxia Inc Announces 2421 5M Series D Financing 4628 1CoAxia Inc Announces 2421 5M Series D Financing 4628 2CoAxia Inc Announces 2421 5M Series D Financing 4628 3Lilly Declares Third Quarter Dividend 49687 1
...e II study extension shows 68-73% of patients with... three years of treatment with oral FTY720,- New d...rain lesions - the injury caused by MS - thr...ating disease causing progressive disability, affe...g many young adults - FTY720 regulatory filings p...
... MEK inhibitor, RDEA119, demonstrates potential fo...nary Phase 1 results -, - Next generation MEK inh... half of 2008 -, SAN DIE...EA ) today announced that data was presented demon...okinetic profile of the Company,s,mitogen-activate...
Other Medicine Technology:FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 2FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 3FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 4FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 5FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 6Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 2Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 3Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 4
Polymax
Sononav Intraoperative Imaging System
...the two steps are performed in sequence automatica...use disposable cartridge and placed in the dual ac... the cycle begins. The platelet plasma is separate...p concentrates fibrinogen, platelets and all other...
Syringe Avitene
Medicine Products: